【卷号】SHANGHAI FIRST PEOPLE'S HOSPITAL;CHENGDU KANGHONG PHARMACEUTICAL GROUP CO LTD
【页码】CN105859833;|2016.08.17
【ISSN】CN201510036411.0
【分类号】C07K7/06
【摘要】The invention belongs to the biological medicine field, and in particular, relates to a polypeptide for inhibition of blood vessel neogenesis or growth, a coding sequence, a vector containing the coding sequence, host cells, pharmaceutical compositions and a pharmaceutical use of the polypeptide. The polypeptide has the advantages of small molecular weight, good water solubility, high safety and good stability, and can be prepared by a solid phase synthesis method and the purity is high, the yield is high and the cost is low.
